Semnur Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Semnur Pharmaceuticals, Inc. has filed 219 SEC EDGAR filings since 01 Mar 2022

SEC filing history

Showing 126-150 of 219 matching filings.

Per page
25
Current page
6
8-K File 001-41351

CURRENT REPORT

Filing date
09 Aug 2024
Reporting date
09 Aug 2024
Next action
Verify source filing
SC 13G File 005-93795

SC 13G filing

Filing date
09 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
17 Jul 2024
Reporting date
15 Jul 2024
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
10 Jul 2024
Reporting date
10 Jul 2024
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
05 Jul 2024
Reporting date
02 Jul 2024
Next action
Verify source filing
DEF 14A File 001-41351

PROXY STATEMENT

Filing date
28 Jun 2024
Reporting date
10 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
27 Jun 2024
Reporting date
26 Jun 2024
Next action
Verify source filing
PRE 14A File 001-41351

PROXY STATEMENT

Filing date
18 Jun 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
22 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
NT 10-Q File 001-41351

NOTIFICATION OF LATE FILING

Filing date
15 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-41351

ANNUAL REPORT

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
27 Feb 2024
Reporting date
22 Feb 2024
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A filing

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93795

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93795

SC 13G

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

SC 13G/A filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

DENALI CAPITAL ACQUISITION CORP

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93795

DECA 13G/A

Filing date
02 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
10 Jan 2024
Reporting date
09 Jan 2024
Next action
Verify source filing
425 File 001-41351

FORM 425

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41351

DEFINITIVE ADDITIONAL MATERIALS

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41351

CURRENT REPORT

Filing date
29 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41351

CURRENT REPORT

Filing date
29 Dec 2023
Reporting date
29 Dec 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .